NicCheck
test has been as the evidence based test to be used to confirm smoking
cessation in the “Quit to Win Challenge” being held in Quebec, Canada.
SMOKING ADDICTION.
Once again, Mossman Associates’ NicCheck test has
been chosen to be the evidence based test used to confirm smoking
cessation in the “Quit to Win Challenge” being held in Quebec Canada.
The 2016 edition of the “Quit to Win Challenge” annual campaign started
on March 1st and will end on April 11th. After that time winners will
be selected and tested as they have done in previous years using our NicCheck product.
“We are proud to continue our support of these types of contests”, quotes Donald Mossman, President of Mossman Associates.
He continues, “Competitions
like these in Romania, Canada, and Taiwan are instrumental in helping
people break the smoking habit. We look forward to working with other
countries, universities and organizations that initiate on these types
of programs”.
NicCheck
is a dry chemistry dipstick for the semi-quantitative measurement of
nicotine and nicotine metabolites in urine as an aid in the verification
of a person’s true smoking status. This 15 minute test yields a
semi-quantitative measurement of a person’s nicotine consumption based
on the color intensity of the reaction found on the NicCheck test strips.
About Mossman Associates, Inc.
Mossman Associates, Inc
is a privately held medical device company that specializes in rapid
tests for physicians and researchers as well as equipment and reagents
for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.
